Literature DB >> 11306651

Na+- and Cl--coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes.

T Nakanishi1, T Hatanaka, W Huang, P D Prasad, F H Leibach, M E Ganapathy, V Ganapathy.   

Abstract

1. ATB(0,+) is an amino acid transporter energized by transmembrane gradients of Na+ and Cl(-) and membrane potential. We cloned this transporter from mouse colon and expressed the clone functionally in mammalian (human retinal pigment epithelial, HRPE) cells and Xenopus laevis oocytes to investigate the interaction of carnitine and its acyl esters with the transporter. 2. When expressed in mammalian cells, the cloned ATB(0,+) was able to transport carnitine, propionylcarnitine and acetylcarnitine. The transport process was Na(+) and Cl(-) dependent and inhibitable by the amino acid substrates of the transporter. The Michaelis constant for carnitine was 0.83 +/- 0.08 mM and the Hill coefficient for Na(+) activation was 1.6 +/- 0.1. 3. When expressed in Xenopus laevis oocytes, the cloned ATB(0,+) was able to induce inward currents in the presence of carnitine and propionylcarnitine under voltage-clamped conditions. There was no detectable current in the presence of acetylcarnitine. Carnitine-induced currents were obligatorily dependent on the presence of Na(+) and Cl(-). The currents were saturable with carnitine and the Michaelis constant was 1.8 +/- 0.4 mM. The analysis of Na(+)- and Cl(-)-activation kinetics revealed that 2 Na(+) and 1 Cl(-) were involved in the transport of carnitine via the transporter. 4. These studies describe the identification of a novel function for the amino acid transporter ATB(0,+). Since this transporter is expressed in the intestinal tract, lung and mammary gland, it is likely to play a significant role in the handling of carnitine in these tissues. 5. A Na(+)-dependent transport system for carnitine has already been described. This transporter, known as OCTN2 (novel organic cation transporter 2), is expressed in most tissues and transports carnitine with high affinity. It is energized, however, only by a Na(+) gradient and membrane potential. In contrast, ATB(0,+) is a low-affinity transporter for carnitine, but exhibits much higher concentrative capacity than OCTN2 because of its energization by transmembrane gradients of Na(+) and Cl(-) as well as by membrane potential.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306651      PMCID: PMC2278546          DOI: 10.1111/j.1469-7793.2001.0297f.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  19 in total

Review 1.  Structure of renal organic anion and cation transporters.

Authors:  G Burckhardt; N A Wolff
Journal:  Am J Physiol Renal Physiol       Date:  2000-06

2.  beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter.

Authors:  M E Ganapathy; W Huang; D P Rajan; A L Carter; M Sugawara; K Iseki; F H Leibach; V Ganapathy
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

3.  Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.

Authors:  X Wu; W Huang; P D Prasad; P Seth; D P Rajan; F H Leibach; J Chen; S J Conway; V Ganapathy
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

4.  Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+).

Authors:  J L Sloan; S Mager
Journal:  J Biol Chem       Date:  1999-08-20       Impact factor: 5.157

5.  Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.

Authors:  K Yokogawa; Y Higashi; I Tamai; M Nomura; N Hashimoto; H Nikaido; J Hayakawa; K Miyamoto; A Tsuji
Journal:  J Pharmacol Exp Ther       Date:  1999-04       Impact factor: 4.030

6.  Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.

Authors:  R Ohashi; I Tamai; H Yabuuchi; J I Nezu; A Oku; Y Sai; M Shimane; A Tsuji
Journal:  J Pharmacol Exp Ther       Date:  1999-11       Impact factor: 4.030

7.  Carnitine transport and its inhibition by sulfonylureas in human kidney proximal tubular epithelial cells.

Authors:  W Huang; S N Shaikh; M E Ganapathy; U Hopfer; F H Leibach; A L Carter; V Ganapathy
Journal:  Biochem Pharmacol       Date:  1999-10-15       Impact factor: 5.858

Review 8.  Carnitine metabolism and its regulation in microorganisms and mammals.

Authors:  C J Rebouche; H Seim
Journal:  Annu Rev Nutr       Date:  1998       Impact factor: 11.848

Review 9.  Genetic disorders of carnitine metabolism and their nutritional management.

Authors:  J Kerner; C Hoppel
Journal:  Annu Rev Nutr       Date:  1998       Impact factor: 11.848

10.  Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.

Authors:  I Tamai; R Ohashi; J Nezu; H Yabuuchi; A Oku; M Shimane; Y Sai; A Tsuji
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

View more
  41 in total

1.  Absorbing competition for carnitine.

Authors:  P M Taylor
Journal:  J Physiol       Date:  2001-04-15       Impact factor: 5.182

Review 2.  Small bowel review: Normal physiology, part 1.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

3.  Isolation and molecular characterization of the porcine SLC6A14 gene excludes it as a candidate gene for fat deposition and growth.

Authors:  G L Yang; J Ren; S H Zhang; W B Huang; Y M Guo; Y Y Duan; M Z Liu; L S Huang
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

4.  Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice.

Authors:  Prem S Shekhawat; Sonne R Srinivas; Dietrich Matern; Michael J Bennett; Richard Boriack; Varghese George; Hongyan Xu; Puttur D Prasad; Penny Roon; Vadivel Ganapathy
Journal:  Mol Genet Metab       Date:  2007-09-19       Impact factor: 4.797

Review 5.  The functional and molecular entities underlying amino acid and peptide transport by the mammary gland under different physiological and pathological conditions.

Authors:  D B Shennan; C A R Boyd
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-25       Impact factor: 2.673

6.  Computational prediction of CNS drug exposure based on a novel in vivo dataset.

Authors:  Christel A S Bergström; Susan A Charman; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2012-06-29       Impact factor: 4.200

Review 7.  Carnitine biosynthesis in mammals.

Authors:  Frédéric M Vaz; Ronald J A Wanders
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

8.  Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells.

Authors:  Erik Rytting; Jordan Bryan; Marylee Southard; Kenneth L Audus
Journal:  Biochem Pharmacol       Date:  2006-12-01       Impact factor: 5.858

Review 9.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

10.  Functional features and genomic organization of mouse NaCT, a sodium-coupled transporter for tricarboxylic acid cycle intermediates.

Authors:  Katsuhisa Inoue; You-Jun Fei; Lina Zhuang; Elangovan Gopal; Seiji Miyauchi; Vadivel Ganapathy
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.